Clorgiline

Clorgiline
Clinical data
Other namesClargyline
Drug classMonoamine oxidase inhibitor; MAO-A inhibitor
ATC code
  • None
Legal status
Legal status
  • In general: uncontrolled
Identifiers
  • N-[3-(2,4-dichlorophenoxy)propyl]-N-methyl-prop-2-yn-1-amine
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H15Cl2NO
Molar mass272.17 g·mol−1
3D model (JSmol)
  • Clc1cc(Cl)ccc1OCCCN(CC#C)C
  • InChI=1S/C13H15Cl2NO/c1-3-7-16(2)8-4-9-17-13-6-5-11(14)10-12(13)15/h1,5-6,10H,4,7-9H2,2H3 Y
  • Key:BTFHLQRNAMSNLC-UHFFFAOYSA-N Y
 NY (what is this?)  (verify)

Clorgiline (INNTooltip International Nonproprietary Name), or clorgyline (BANTooltip British Approved Name), is a monoamine oxidase inhibitor (MAOI) and investigational antidepressant related to pargyline. Specifically, it is an irreversible and selective inhibitor of monoamine oxidase A (MAO-A). Clorgiline was never marketed, but it has found use in scientific research.

In addition to its MAOI activity, it has been found to bind with high affinity to the σ1 receptor (Ki = 3.2–510 nM) and with very high affinity to the imidazoline I2 receptor (Ki = 40 pM). Unlike selegiline, clorgiline does not appear to be a monoaminergic activity enhancer (MAE).

Clorgiline is also a multidrug efflux pump inhibitor. Holmes et al., 2012 reverse azole fungicide resistance using clorgiline, showing promise for its use in multiple fungicide resistance.